2023 annual financial data
Damora Therapeutics 2023 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -36,457,000 USD and net income was -38,349,000 USD.
Operating cash flow was -36,911,000 USD.
Get free Damora Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -36,457,000 USD
- Net income
- -38,349,000 USD
- Operating cash flow
- -36,911,000 USD